Galangin promotes apoptosis by upregulating the pro-apoptotic gene BAX in triple-negative breast cancer
This study's results demonstrate that Galangin possesses considerable anti-proliferative effects on TNBC cells, underscoring its potential as a viable therapeutic drug. These findings facilitate the development of more effective and precisely focused therapy approaches for TNBC, providing optimism for enhanced treatment outcomes for patients suffering from this challenging disease.
Authors
- Vaibhav Sunil Ladke (ORCID: https://orcid.org/0000-0002-6327-3378)
- Poonam V. Suryawanshi (ORCID: https://orcid.org/0000-0002-4352-5339)
- Ajinkya Dilip
- Jitendra Bhawalkar
- Shruti Sinnarkar
Institutions
- Dr. D. Y. Patil Medical College, Hospital and Research Centre (IN)
- Institute for Research and Development (LK)
- Dr. D.Y. Patil Vidyapeeth, Pune (IN)
Publication Details
- Journal
- Journal of the Egyptian National Cancer Institute
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1186/s43046-024-00246-y
- Citations
- 4
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 1.45